Childhood cancer survival in France, 1990–1999

Désandes, Emmanuel; Berger, Claire; Tron, Isabelle; Deméocq, F.; Bellec, Stéphanie; Blouin, P.; Casagranda, Léonie; Lumley, L. De; Freyçon, F; Goubin, Aurélie; Gall, E. Le; Santini, Daniele; Lacour, Brigitte; Clavel, Jacqueline

doi:10.1016/j.ejca.2007.11.016

Cited by 42 publications

(39 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Stage at diagnosis is another important determinant of survival among children with some specific cancers (6,22), and further modeling to adjust for stage was carried out on the subset of cases for which these data were collected.…”

Section: Poisson Modelsmentioning

confidence: 99%

Differentials in Survival for Childhood Cancer in Australia by Remoteness of Residence and Area Disadvantage

Youlden

Baade

Valery

et al. 2011

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

Background: It is not known whether improvements in cancer survival over recent decades have benefited children from different geographic locations equally. This is the first study to produce national survival estimates for childhood cancer in Australia by remoteness of residence and area-based socioeconomic status.Methods: The study utilized population-based data from the Australian Paediatric Cancer Registry for children diagnosed with cancer from 1996 onward who were at risk of mortality between January 2001 and December 2006 (n ¼ 6,289). Remoteness was specified according to the Australian Standard Geographical Classification Remoteness Areas, whereas an index of area disadvantage was obtained from census information. Five-year relative survival estimates were produced by the period method for all cancers and the most common diagnostic groups, with corresponding age-sex adjusted mortality hazard ratios calculated using Poisson regression.Results: Overall, children with cancer from remote/very remote areas had a significantly lower survival rate than their counterparts in major cities (HR ¼ 1.55, 95% CI ¼ 1.08-2.23). Survival was also lower for children with leukemia living in inner regional (HR ¼ 1.52, 95% CI ¼ 1.11-2.08) or outer regional areas (HR ¼ 1.53, 95% CI ¼ 1.03-2.28). There was weak evidence (P grad ¼ 0.051) of a trend toward poorer survival by greater area disadvantage for all childhood cancers.Conclusions: Some variation in prognosis by place of residence was present for children with cancer in Australia, particularly among leukemia patients.Impact: Treatment, clinical or area-related factors that contribute to these survival differentials need to be identified. Cancer Epidemiol Biomarkers Prev; 20(8); 1649-56. Ó2011 AACR.

show abstract

Section: Poisson Modelsmentioning

confidence: 99%

Differentials in Survival for Childhood Cancer in Australia by Remoteness of Residence and Area Disadvantage

Youlden

Baade

Valery

et al. 2011

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

show abstract

“…In France, the child CNST management is highly specific and requires certification issued by the French National Health Authority. While some national publications are available [1,11,12], regional assessments in France are crucial to provide CNST frequency, incidence and survival data in order to evaluate these specific pediatric units. CNST: central nervous system tumors; ICD-O-3: International Classification of Diseases for Oncology 3rd ed.…”

Section: Discussionmentioning

confidence: 99%

Incidence and survival of childhood central nervous system tumors: A report of the regional registry of childhood cancers in Auvergne-Limousin

et al. 2015

View full text Add to dashboard Cite

“…Les données de survie actuellement disponibles en France proviennent, d'une part, des registres régionaux pédiatriques pour l'ensemble des cancers de l'enfant sur la période 1990-1999 [9] [12].…”

Section: Survieunclassified

“…Répartition des différents types de cancers selon l'âge (Registre national des hémopathies malignes de l'enfant et Registre national des tumeurs solides de l'enfant, (suite) pédiatriques, notamment des LAL, des sarcomes d'Ewing et des rhabdomyosarcomes, était plus faible chez l'adolescent que chez l'enfant[9]. Comme chez l'enfant, la survie à cinq ans s'est améliorée au cours du temps, passant de 70 % pour la période 1988-1992 à 78 % pour la période 1993-1997.…”

unclassified

Cancers de l’enfant et de l’adolescent: de quoi parlons-nous ?

et al. 2011

View full text Add to dashboard Cite

In France, cancer hits around 1,700 children (0-14 years) and 700 adolescents (15-19 years) each year. In other terms, one child out of 440 developes a cancer before the age of 15 in industrial countries, and 1 out of 300 before the age of 20. Five-year survival after childhood cancer has dramatically improved in the last 30 years, reaching yet 80%. A very small fraction of cases is attributable to known risk factors such as heritable cancers and heritable predisposing diseases, high-dose ionizing radiation, chemotherapeutic drugs. Other factors are suspected, such as lack of common infections in early childhood in leukaemia, or prenatal exposure to household pesticides in many cancers. To cite this journal: Oncologie 13 (2011).

show abstract

Childhood cancer survival in France, 1990–1999

Cited by 42 publications

References 42 publications

Differentials in Survival for Childhood Cancer in Australia by Remoteness of Residence and Area Disadvantage

Differentials in Survival for Childhood Cancer in Australia by Remoteness of Residence and Area Disadvantage

Incidence and survival of childhood central nervous system tumors: A report of the regional registry of childhood cancers in Auvergne-Limousin

Cancers de l’enfant et de l’adolescent: de quoi parlons-nous ?

Contact Info

Product

Resources

About